SEC 13F Intelligence

Trails Edge Capital Partners, LP / CMPX

Trails Edge Capital Partners, LP’s Compass Therapeutics Inc Position

Does Trails Edge Capital Partners, LP own Compass Therapeutics Inc (CMPX)? Not currently — the last reported position was 1.42M shares worth $8M in Q4 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q4 2025
Shares
1.42M
% of Portfolio
+1.88%
Quarters Held
1
position exited

Position History CMPX

Reported value by quarter
Q4 ’25: $8MQ4 ’25filingsflow.com
QuarterSharesValue% of Portfolio
Q4 20251.42M$8M+1.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of CMPX.